Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia

Bibliographic Details
Main Authors:	P. J. Hengeveld, J. Schilperoord-Vermeulen, M. Y. van der Klift, J. M. N. Dubois, P. M. Kolijn, F. G. Kavelaars, M. Rijken, J. A. Dobber, K. Nasserinejad, S. Kersting, P. E. Westerweel, A. P. Kater, A. W. Langerak, M-D. Levin
Format:	Article
Language:	English
Published:	Nature Publishing Group 2023-07-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-023-00870-2

Internet